Related Experiment Videos

Liposomal cancer chemotherapy: current clinical applications and future prospects

K J Harrington¹

¹Chester Beatty Laboratories, Institute of Cancer Research, 237 Fulham Rd, London SW3 6JB, UK.

Expert Opinion on Investigational Drugs

|January 5, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.

Oral oncology·2023

OX40 and 4-1BB delineate distinct immune profiles in sarcoma.

Oncoimmunology·2022

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.

Clinical and translational radiation oncology·2018

An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity.

Clinical oncology (Royal College of Radiologists (Great Britain))·2018

Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2018

See all related articles